Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience

por Cutuli, B, Lemanski, C, Fourquet, A, de Lafontan, B, Giard, S, Meunier, A, Pioud-Martigny, R, Campana, F, Marsiglia, H, Lancrenon, S, Mery, E, Penault-Llorca, F, Fondrinier, E, Tunon de Lara, C
Publicado 2009

Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer

por Moyes, L H, Leitch, E F, McKee, R F, Anderson, J H, Horgan, P G, McMillan, D C
Publicado 2009

Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts

por Cao, P, Maira, S-M, García-Echeverría, C, Hedley, D W
Publicado 2009

BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers

por Hirata, Y, Ogasawara, N, Sasaki, M, Mizushima, T, Shimura, T, Mizoshita, T, Mori, Y, Kubota, E, Wada, T, Tanida, S, Kataoka, H, Kamiya, T, Higashiyama, S, Joh, T
Publicado 2009

DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure

por Kettunen, E, Aavikko, M, Nymark, P, Ruosaari, S, Wikman, H, Vanhala, E, Salmenkivi, K, Pirinen, R, Karjalainen, A, Kuosma, E, Anttila, S
Publicado 2009

TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy

por Oden-Gangloff, A, Di Fiore, F, Bibeau, F, Lamy, A, Bougeard, G, Charbonnier, F, Blanchard, F, Tougeron, D, Ychou, M, Boissière, F, Le Pessot, F, Sabourin, J-C, Tuech, J-J, Michel, P, Frebourg, T
Publicado 2009

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

por Huhtinen, K, Suvitie, P, Hiissa, J, Junnila, J, Huvila, J, Kujari, H, Setälä, M, Härkki, P, Jalkanen, J, Fraser, J, Mäkinen, J, Auranen, A, Poutanen, M, Perheentupa, A
Publicado 2009

O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib

por Watson, A J, Middleton, M R, McGown, G, Thorncroft, M, Ranson, M, Hersey, P, McArthur, G, Davis, I D, Thomson, D, Beith, J, Haydon, A, Kefford, R, Lorigan, P, Mortimer, P, Sabharwal, A, Hayward, O, Margison, G P
Publicado 2009

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

por Ambros, P F, Ambros, I M, Brodeur, G M, Haber, M, Khan, J, Nakagawara, A, Schleiermacher, G, Speleman, F, Spitz, R, London, W B, Cohn, S L, Pearson, A D J, Maris, J M
Publicado 2009

Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?

por Postel-Vinay, S, Arkenau, H-T, Olmos, D, Ang, J, Barriuso, J, Ashley, S, Banerji, U, De-Bono, J, Judson, I, Kaye, S
Publicado 2009

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor

por Dudek, A Z, Lesniewski-Kmak, K, Shehadeh, N J, Pandey, O N, Franklin, M, Kratzke, R A, Greeno, E W, Kumar, P
Publicado 2009

Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway

por Presneau, N, Shalaby, A, Idowu, B, Gikas, P, Cannon, S R, Gout, I, Diss, T, Tirabosco, R, Flanagan, A M
Publicado 2009

Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines

por Mahalingam, D, Keane, M, Pirianov, G, Mehmet, H, Samali, A, Szegezdi, E
Publicado 2009

Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification

por Smith, M J, Culhane, A C, Donovan, M, Coffey, J C, Barry, B D, Kelly, M A, Higgins, D G, Wang, J H, Kirwan, W O, Cotter, T G, Redmond, H P
Publicado 2009

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

por Gronwald, J, Cybulski, C, Piesiak, W, Suchy, J, Huzarski, T, Byrski, T, Gorski, B, Debniak, T, Szwiec, M, Wokolowczyk, D, Matuszewski, M, Sun, P, Lubinski, J, Narod, S A
Publicado 2009

Proton pump inhibitors and risk of gastric cancer: a population-based cohort study

por Poulsen, A H, Christensen, S, McLaughlin, J K, Thomsen, R W, Sørensen, H T, Olsen, J H, Friis, S
Publicado 2009

Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism

por Cambien, B, Karimdjee, B F, Richard-Fiardo, P, Bziouech, H, Barthel, R, Millet, M A, Martini, V, Birnbaum, D, Scoazec, J Y, Abello, J, Saati, T Al, Johnson, M G, Sullivan, T J, Medina, J C, Collins, T L, Schmid-Alliana, A, Schmid-Antomarchi, H
Publicado 2009

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer

por Vasile, E, Masi, G, Fornaro, L, Cupini, S, Loupakis, F, Bursi, S, Petrini, I, Di Donato, S, Brunetti, I M, Ricci, S, Antonuzzo, A, Chiara, S, Amoroso, D, Andreuccetti, M, Falcone, A
Publicado 2009

Risk of cervical abnormality after age 50 in women with previously negative smears

por Blanks, R G, Moss, S M, Addou, S, Coleman, D A, Swerdlow, A J
Publicado 2009

A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk

por Wallström, P, Bjartell, A, Gullberg, B, Olsson, H, Wirfält, E
Publicado 2009